Correlation Between Ascletis Pharma and Neurobiological Technologies

Can any of the company-specific risk be diversified away by investing in both Ascletis Pharma and Neurobiological Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascletis Pharma and Neurobiological Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ascletis Pharma and Neurobiological Technologies, you can compare the effects of market volatilities on Ascletis Pharma and Neurobiological Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascletis Pharma with a short position of Neurobiological Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascletis Pharma and Neurobiological Technologies.

Diversification Opportunities for Ascletis Pharma and Neurobiological Technologies

0.0

Correlation Coefficient

Ascletis Pharma  Neurobiological Technologies

Pay attention - limited upside

The 3 months correlation between Ascletis and Neurobiological is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ascletis Pharma and Neurobiological Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobiological Technologies and Ascletis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascletis Pharma are associated (or correlated) with Neurobiological Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobiological Technologies has no effect on the direction of Ascletis Pharma i.e., Ascletis Pharma and Neurobiological Technologies go up and down completely randomly.

Pair Corralation between Ascletis Pharma and Neurobiological Technologies

If you would invest  24.00  in Ascletis Pharma on December 26, 2024 and sell it today you would earn a total of  96.00  from holding Ascletis Pharma or generate 400.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Ascletis Pharma  vs.  Neurobiological Technologies

Ascletis Pharma

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Neurobiological Technologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neurobiological Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Neurobiological Technologies is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Ascletis Pharma and Neurobiological Technologies

The main advantage of trading using opposite Ascletis Pharma and Neurobiological Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascletis Pharma position performs unexpectedly, Neurobiological Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobiological Technologies will offset losses from the drop in Neurobiological Technologies' long position.

The idea behind Ascletis Pharma and Neurobiological Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.